InsidersTradesSigma
Track the Grifols, S.A. stock price and the full management transaction log of the company, a listed equity based in Spain. Shares are quoted on the ES market, under the supervision of CNMV. Operating in the Health Care sector, Grifols, S.A. has published 0 public disclosures. Market capitalisation: €6.2bn. Every trade is accessible without an account.
Analysts rate Grifols, S.A. Buy (bullish), based on 12 analysts. Average price target: €14.40.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
Grifols, S.A. is a Spanish company specializing in the healthcare and pharmaceutical sector, known for its plasma-derived products. It is listed on the Spanish stock market, XMAD.